† In this retrospective study of 844 patients undergoing cardiac surgery, increased LV mass correlated closely with 30 day mortality but not at 1 yr. † Some standard data were not collected; these findings need to be corroborated against a recognized international preoperative risk scoring system.
Background. Increased left ventricular mass (LVM) is a well-recognized predictor of cardiovascular morbidity and mortality in epidemiological studies, but its impact on mortality after cardiac surgery is poorly defined. We hypothesized that patients with increased LVM index (LVMI) were more likely to have greater 30 day and 1 yr mortality.
Methods. With IRB approval, intraoperative transoesophageal echocardiography images of 844 cardiac surgical patients were reviewed. LVMI was calculated using the American Society of Echocardiography recommended formula. Outcome variables studied were 30 day and 1 yr mortality.
Results. Mortality within 30 days occurred in 28 patients (3.3%) and within 1 yr in 91 patients (10.8% ). An almost linear relationship was found between increasing LVMI and the risk of mortality within 30 days of cardiac surgery. The odds ratio (OR) of dying within 30 days of surgery was 1.15 Conclusions. Increased LVMI, but not LV systolic function as measured by the fractional area of contraction (FAC) was identified as a strong independent predictor of perioperative mortality after adult cardiac surgery. The relationship between LVMI and risk of 30 day mortality was nearly linear. Furthermore, decreased FAC, and not LVMI, was a strong independent predictor of 1 yr mortality.
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The Framingham Heart Study investigators and others have demonstrated that increased left ventricular mass (LVM), measured by echocardiography, is a powerful independent predictor of cardiovascular morbidity and mortality. 1 -3 Increased LVM has also been associated with coronary artery disease, all-cause mortality, and sudden death. 4 5 As such, the diagnosis of increased LVM has been incorporated into clinical practice as an important marker of cardiovascular disease. Many patients undergoing cardiac surgery have increased LVM. LVM increases as an adaptive mechanism to help limit systolic wall stress and preserve ejection fraction (EF) in patients with ventricular pressure or volume overload. 5 LVM has not been studied extensively as a predictor of short-and long-term mortality after cardiac surgery. Several studies have found that increased LVM is a risk factor for in-hospital mortality after aortic valve replacement. 6 -8 However, long-term mortality and other types of cardiac surgery have not been studied. We hypothesized that risk stratification for patients undergoing cardiac surgery and timing of surgery may be improved by incorporating LVM into the preoperative risk assessment, and specifically that patients with increased LVM index (LVMI) measured by transoesophageal echocardiography (TOE) were more likely to have increased 30 day and 1 yr mortality.
Methods
After receiving IRB approval, we investigated retrospectively a group of 844 adult patients who underwent all types of cardiac surgery at our institution between August 2008 and July 2009. Initially, 1000 patients were identified to be studied; however, only 844 had images of adequate quality for quantification of LVMI to be included in the study. The medical charts were reviewed to obtain patient and surgical characteristics, including age, weight, height, gender, Canadian Cardiovascular Society class, 9 the All Patient Refined-score, and the type of surgery. Outcome variables studied were 30 day and 1 yr mortality. APR-DRG scores are calculated from discharge billing codes and are based on primary and secondary discharge diagnosis, age, and pre-existing medical conditions and are used as a mortality risk adjustor. 10 APR-DRG ranks the ROM as low, medium, high, and extreme. For analysis relating to the type of surgery, the patients were divided into three groups. One group consisted of patients having isolated coronary artery bypass grafting (CABG). The second group included patients having cardiac valvular surgery or combined valve and CABG surgery. The third group comprised patients who underwent thoracic aortic surgery.
It is our standard practice for all patients undergoing adult cardiac surgery to undergo an intraoperative TOE examination. Video clips of the exam are stored on a dedicated image storage server. The intraoperative TOE images were reviewed by a board certified (NBE) echocardiographer to calculate LVM and the fractional area of contraction (FAC) of the left ventricle (LV). LVM was calculated using the American Society of Echocardiography-recommended linear formula involving posterior (PWTd) and septal wall (SWTd) thicknesses and LV internal diameter (LVIDd) at end-diastole:
LVM was indexed to body surface area and calculated using the Mosteller 12 formula. The reference ranges were those recommended by the American Society of Echocardiography (Table 1) .
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Statistical methods
For group comparisons, x 2 or Fisher's exact tests were used for categorical variables, Student's t-tests or analysis of variance for normally distributed continuous variables, and Wilcoxon rank-sum tests or Kruskal-Wallis tests for nonnormally distributed continuous or rank variables. A logistic regression model with stepwise selection was used to investigate specific study variables for the outcome variables of 30 day and 1 yr mortality. The initial list in stepwise selection included LVMI, age, weight, and FAC grade of ventricular dysfunction (mild, moderate, or severe). Interactions between identified significant risk factors and LVMI were further tested to see if the effect of LVMI on mortality depended on the status of other risk factors. A P-value of ,0.05 was considered to be statistically significant.
Results
Eight hundred and forty-four patients had echocardiographic images of adequate quality for quantification of LVMI to be included in the study (Table 2) 
Thirty day mortality
Using univariate analysis, we compared the incidence of different variables in patients who did and did not die within 30 days of surgery ( 
One year mortality
Using univariate analysis, we compared the incidence of different variables in patients who did and did not die within 1 yr of surgery (Table 3 ). The patients who died were older, had poorer LV function, belonged to a more advanced CCS class, and were more likely to have a higher APR-DRG ROM score. Increased LVMI, however, was not statistically significant. In addition, type of surgery, weight, and gender had no significant association with 1 yr mortality. 
Discussion
In this study, we identified increased LVMI and not LV systolic function, as measured by FAC, as an independent predictor of 30 day mortality after adult cardiac surgery, particularly in patients with lower APR-DRG ROM scores. The relationship between LVMI and risk of 30 day mortality was nearly linear. In contrast, however, decreased LV systolic function, as measured by FAC, and not LVMI, was a strong independent predictor of 1 yr mortality. LVM increases as a result of cellular myocardial hypertrophy and increased myocardial fibrosis. Myocardial hypertrophy and fibrosis impair the diastolic function of the LV by increasing its stiffness and delaying its relaxation. 13 Patients with increased LVMI are also at increased risk for perioperative myocardial ischaemia due to structural changes of the intramyocardial coronary vasculature, increased coronary resistance, coronary flow abnormalities, and impaired subendocardial blood flow owing to increases in LV end-diastolic pressure. Furthermore, myocardial oxygen demand is increased as a result of the increased LVM and higher wall stress. During surgery, patients with severe LVH are also at increased risk for suboptimal myocardial protection, which may result in increased risk for development of myocardial dysfunction or arrhythmias. 6 7 These factors all combine to lead to worse 30 day mortality. Increased LVM has been demonstrated in epidemiological studies to be independently associated with adverse cardiovascular outcomes, including myocardial infarction, congestive heart failure, stroke, and death in patients with hypertension, asymptomatic aortic stenosis, and in the general population. 1 2 14 15 In a meta-analysis, Vakili and colleagues 16 showed that the risk of future cardiovascular morbidity or mortality is doubled for those with severely increased LVM. The regression of LVM in response to therapy for hypertension is associated with better prognosis independent of arterial pressure reduction. 17 18 Our results are similar to other studies showing that increased LVM is associated with increased in-hospital mortality after aortic valve replacement. 6 -8 However, our study is one of the largest looking at LVMI and cardiac surgery outcomes and is also the first study to include all types of cardiac surgery; we found no significant difference between different types of surgery.
The most surprising finding of the study was the lack of association between LVMI and 1 yr mortality. We expected to find a difference there as well, as seen in the epidemiological studies. Perhaps, if a perioperative insult is averted despite increased LVMI, it is evidence that the patient has compensated well and is less susceptible to long-term mortality.
Our finding that LV systolic function was not associated with 30 day mortality is consistent with a previous study in patients undergoing CABG where EF did not appear to be an independent predictor of perioperative mortality even in patients with severely depressed LV function (EF,20%), but was a predictor of 1 yr mortality. 19 In contrast, many prior studies found that LV EF was a key prognostic indicator in patients undergoing CABG. 20 21 The lack of association of EF with perioperative mortality has been attributed to improved perioperative care and surgical techniques. However, this benefit is no longer present when analysing 1 yr mortality when these factors no longer apply. Our study also validated once again the use of the APR-DRG ROM score as a mortality risk adjustor. Both 30 day and 1 yr mortality were significantly associated with higher scores.
The patients included in this investigation were representative of an adult cardiac surgery population seen at a tertiary care hospital. The limitations of the study included its retrospective, single-centre design and that a single investigator made the echocardiographic measurements. We also did not investigate diastolic function or factors that affect myocardial preservation such as aortic cross-clamp time or cardioplegia technique. Furthermore, due to the retrospective nature of the study, we did not have the EuroSCORE or a similar cardiac surgical scoring system available to include in our analysis. Clinical care was not standardized; thus, the effects of unmeasured confounding variables cannot be excluded.
In conclusion, this study showed that increased LVMI might be a strong independent predictor of 30 day mortality but not of 1 yr mortality, after all types of cardiac surgery. Furthermore, FAC was a strong independent predictor of 1 yr, but not of 30 day mortality. While this single study is not sufficient to conclude that LVMI should replace LV function in preoperative cardiac surgery scoring systems, it will perhaps stimulate further research in this area. Further studies are also required to address whether 30 day mortality could be improved by performing surgery before significant increases in LVMI occur. In the meantime, we suggest that patients with increased LVMI should have special attention with respect to perioperative management, particularly with regard to myocardial oxygen supply/demand balance and myocardial protection.
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